Big Pharma’s Tax Dodging Scheme Stopped In Its Tracks: We Need More Of This!
The biggest drug company in the U.S. won’t be moving to Ireland after all. Pfizer dropped the $150 billion proposed merger deal with Dublin-based Allegran after the Obama Administration cracked down on corporate inversion deals, a move that basically allows a corporation to move their headquarters overseas to cut their U.S. tax bills. The decision means Pfizer will remain a US corporation and the $21 billion in tax revenue it generates will remain in America. Now the future of corporate inversion deals are still murky, but the president and some of the candidates running for his job are renewing their call...
Read More